The Role of Paraoxonase 1 in the Detoxification of Homocysteine Thiolactone

被引:49
作者
Jakubowski, Hieronim [1 ,2 ]
机构
[1] Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland
[2] UMDNJ New Jersey Med Sch, Int Ctr Publ Hlth, Dept Microbiol & Mol Genet, Newark, NJ 07101 USA
来源
PARAOXONASES IN INFLAMMATION, INFECTION, AND TOXICOLOGY | 2010年 / 660卷
关键词
Autoantibodies; Atherosclerosis; CBS; Fibrinogen; Hyperhomocysteinemia; Homocysteine thiolactone; Immune activation; MTHFR; Paraoxonase/thiolactonase; Protein N-homocysteinylation; Thrombosis; CYSTATHIONINE BETA-SYNTHASE; TRANSFER RNA-SYNTHETASE; MOLECULAR-BASIS; FOLIC-ACID; METHYLENETETRAHYDROFOLATE REDUCTASE; PROTEIN HOMOCYSTEINYLATION; PATHOLOGICAL CONSEQUENCES; DENSITY-LIPOPROTEINS; POSSIBLE MECHANISM; SERUM PARAOXONASE;
D O I
10.1007/978-1-60761-350-3_11
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The thioester homocysteine (Hcy)-thiolactone, product of an error-editing reaction in protein biosynthesis, forms when Hey is mistakenly selected by methionyl-tRNA synthetase. Accumulating evidence suggests that Hcy-thiolactone plays an important role in atherothrombosis. The thioester chemistry of Hcy-thiolactone underlies its ability to form isopeptide bonds with protein lysine residues, which impairs or alters protein function and has pathophysiological consequences including activation of an autoimmune response and enhanced thrombosis. Mammalian organisms, including human, have evolved the ability to eliminate Hcy-thiolactone. One such mechanism involves paraoxonase 1 (PON1), which has the ability to hydrolyze Hcy-thiolactone. This article outlines Hcy-thiolactone pathobiology and reviews evidence documenting the role of PON1 in minimizing Hcy-thiolactone and N-Hcy-protein accumulation.
引用
收藏
页码:113 / 127
页数:15
相关论文
共 77 条
[1]   Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia [J].
Beltowski, J ;
Wojcicka, G ;
Jamroz, A .
ATHEROSCLEROSIS, 2003, 170 (01) :21-29
[2]  
BELTOWSKI J, 2008, 3 INT C PAR 2008 LOS
[3]   Plasma homocysteine is a determinant of tissue necrosis factor-α in hypertensive patients [J].
Bogdanski, P. ;
Pupek-Musialik, D. ;
Dytfeld, J. ;
Lacinski, M. ;
Jablecka, A. ;
Jakubowsk, H. .
BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (06) :360-365
[4]   Homocysteine lowering and cardiovascular events after acute myocardial infarction [J].
Bonaa, KH ;
Njolstad, I ;
Ueland, PM ;
Schirmer, H ;
Tverdal, A ;
Steigen, T ;
Wang, H ;
Nordrehaug, JE ;
Arnesen, E ;
Rasmussen, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (15) :1578-1588
[5]   Urinary excretion of homocysteine-thiolactone in humans [J].
Chwatko, G ;
Jakubowski, H .
CLINICAL CHEMISTRY, 2005, 51 (02) :408-415
[6]   The determination of homocysteine-thiolactone in human plasma [J].
Chwatko, G ;
Jakubowski, H .
ANALYTICAL BIOCHEMISTRY, 2005, 337 (02) :271-277
[7]   Mutations in methylenetetrahydrofolate reductase or cystathionine β-syntase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice [J].
Chwatko, Grazyna ;
Boers, Godfried H. J. ;
Strauss, Kevin A. ;
Shih, Diana M. ;
Jakubowski, Hieronim .
FASEB JOURNAL, 2007, 21 (08) :1707-1713
[8]   Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia [J].
Clarke, Robert ;
Lewington, Sarah ;
Sherliker, Paul ;
Armitage, Jane .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (01) :32-39
[9]   High exogenous homocysteine modifies eye development in early chick embryos [J].
de las Casas, CM ;
Epeldegui, M ;
Tudela, C ;
Varela-Moreiras, G ;
Pérez-Miguelsanz, J .
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2003, 67 (01) :35-40
[10]   The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status [J].
Domagala, T. B. ;
Lacinski, M. ;
Trzeciak, W. H. ;
Mackness, B. ;
Mackness, M. I. ;
Jakubowski, H. .
CELLULAR AND MOLECULAR BIOLOGY, 2006, 52 (05) :4-10